Get started
Author

Lakshmi Manasa S. Chekka

Observed names: Lakshmi Manasa Chekka, Lakshmi Manasa S Chekka
ORCID: 0000-0001-5996-9180
Observed ORCID: 0000-0001-5996-9180
OpenAlex ID: A5007471493
Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults
2025 · Jeffry Florian, Pablo Salcedo, et al. · JAMA Internal Medicine · 35
PDF
Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension
2022 · Lakshmi Manasa S. Chekka, Taimour Langaee, et al. · Frontiers in Genetics · 17
Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis
2021 · Marwa Tantawy, Lakshmi Manasa Chekka, et al. · Frontiers in Cardiovascular Medicine · 13
PDF
Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics
2022 · Paula L. Hyland, Lakshmi Manasa S. Chekka, et al. · Clinical Pharmacology & Therapeutics · 10
Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone
2021 · Lakshmi Manasa S. Chekka, Arlene B. Chapman, et al. · The American Journal of Medicine · 8
Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study
2022 · Nicole D. Armstrong, Vinodh Srinivasasainagendra, et al. · Genes · 7
PDF
Circulating microRNA Biomarkers of Thiazide Response in Hypertension
2024 · Lakshmi Manasa S. Chekka, Marwa Tantawy, et al. · Journal of the American Heart Association · 5
PDF
Pairwise comparison of hydrochlorothiazide and chlorthalidone responses among hypertensive patients
2022 · Lakshmi Manasa S. Chekka, Rhonda M. Cooper‐DeHoff, et al. · Clinical and Translational Science · 5
PDF
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics to Inform Potential Utility in Biosimilar Development
2025 · Lakshmi Manasa S. Chekka, Deepti P. Samarth, et al. · Clinical Pharmacology & Therapeutics · 3
Evaluating miRNA Sequencing and Integrative Proteomics for Identifying Plasma miRNAs as Potential Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics
2025 · Mai Mehanna, Lakshmi Manasa Chekka, et al. · Clinical and Translational Science · 1
PDF
Proteomic Identification of Plasma Biomarkers of Response to IL‐5 Inhibitor Biologics in Healthy Subjects
2025 · Lakshmi Manasa S. Chekka, Deepti P. Samarth, et al. · Clinical and Translational Science · 1
PDF
Abstract 15012: Lactate Dehydrogenase B and Pyruvate Oxidation Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: A Multi-omics Study
2020 · Marwa Tantawy, Lakshmi Manasa Chekka, et al. · Circulation · 1
Omics Biomarkers in Precision Oncology: From the Lens of the ASCPT Biomarkers and Translational Tools and Oncology Communities
2026 · Mai Mehanna, Hardik Mody, et al. · Clinical and Translational Science
Abstract 15986: Plasma Microrna Profiling Reveals Potential Biomarkers of Thiazide Response
2020 · Lakshmi Manasa S Chekka, Taimour Y Langaee, et al. · Circulation
Abstract 3694: Differential expressions of miR-17 and complement factor D in carfilzomib-related cardiotoxicity in multiple myeloma patients: Results of microRNA array and proteomics integrated analysis
2020 · Marwa Tantawy, Lakshmi Manasa Chekka, et al. · Cancer Research
Works count: 15
Citation count: 106
H-index: 6
I10-index: 4
Year
Topic
Type